Published in Nature on August 26, 1976
A Combined Immunofluorescence-DNA-Fluorescence Staining Technique for Enumeration of Thiobacillus ferrooxidans in a Population of Acidophilic Bacteria. Appl Environ Microbiol (1987) 2.85
Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest (1979) 2.42
Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med (1985) 2.12
Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis (1982) 1.99
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis (1986) 1.66
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis (1980) 1.63
DR antigens and rheumatoid arthritis: a study of two populations. Br Med J (Clin Res Ed) (1981) 1.59
Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol (1988) 1.53
Arthritis and coeliac disease. Ann Rheum Dis (1985) 1.43
HLA associations in sarcoidosis: a study of two ethnic groups. Thorax (1984) 1.25
Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology (1991) 1.23
HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med (1982) 1.20
Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis (1986) 1.14
HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs. Br Med J (Clin Res Ed) (1983) 1.14
HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis. Clin Exp Immunol (1988) 1.12
Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. Br Med J (Clin Res Ed) (1984) 1.09
HLA-DR and tuberculin tests in rheumatoid arthritis and tuberculosis. Ann Rheum Dis (1989) 1.08
Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin Exp Immunol (1984) 1.07
Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man. Proc Natl Acad Sci U S A (1981) 1.04
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol (1986) 1.04
HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis. Arch Dis Child (1988) 1.01
Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients. Ann Rheum Dis (1986) 1.01
Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors. J Exp Med (1979) 0.99
HLA antigens and atopy in children with coeliac disease. Gut (1983) 0.99
Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest (1993) 0.97
Behçet's syndrome in Scotland. Postgrad Med J (1992) 0.96
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med (1986) 0.96
Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. Gut (1986) 0.95
Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia (1984) 0.95
The influence of MHC polymorphism on the selection of T-cell determinants of FMDV in cattle. Immunology (1995) 0.93
HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis (1987) 0.90
HLA antigens in coeliac disease associated with malignancy. Gut (1983) 0.87
Is rheumatoid arthritis in Indians associated with HLA antigens sharing a DR beta 1 epitope? Ann Rheum Dis (1991) 0.87
HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease. J Clin Invest (1987) 0.86
Detection of antilymphocyte antibody with two-color method in systemic lupus erythematosus and its heterogeneous specificities against human T-cell subsets. J Clin Invest (1979) 0.86
Seropositivity in Dutch Crohn's disease patients against primed nude mouse lymph nodes, and the difference with lymphocytotoxic antibodies. Gut (1986) 0.84
Month-related variability in immunological test results; implications for immunological follow-up studies. Clin Exp Immunol (1991) 0.84
HLA antigens in psoriasis and psoriatic arthritis. J Med Genet (1985) 0.83
HLA-DR typing in coeliac disease: evidence for genetic heterogeneity. Br Med J (Clin Res Ed) (1984) 0.83
Chromosome 14 markers in rheumatoid arthritis. Ann Rheum Dis (1988) 0.83
HLA-DRw6 and renal allograft rejection. Br Med J (Clin Res Ed) (1983) 0.82
Analysis of HLA-D micropolymorphism by a simple procedure: RNA oligonucleotide hybridization. J Clin Invest (1987) 0.82
New tools and new biology: recent miniaturized systems for molecular and cellular biology. Mol Cells (2013) 0.81
Association between HLA-DR antigens and rheumatoid arthritis in Arabs. Ann Rheum Dis (1990) 0.81
HLA-DR antigens in insulin-dependent diabetes. Arch Dis Child (1981) 0.80
Thygeson's superficial punctate keratitis: natural history and association with HLA DR3. Trans Am Ophthalmol Soc (1981) 0.79
HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. Br Med J (Clin Res Ed) (1985) 0.78
Takayasu's disease in Arabs. Postgrad Med J (1985) 0.78
Antibodies directed against renal collecting ducts in sera of human renal allograft recipients. Clin Exp Immunol (1979) 0.78
Positive, warm T cell crossmatch in cardiac transplantation: with transient vasculitis and without hyperacute rejection. Transplantation (1982) 0.78
DR4 prevalence related to the age at disease onset in female patients with rheumatoid arthritis. Ann Rheum Dis (1989) 0.77
Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation. Clin Exp Immunol (1993) 0.77
Genetic control of immune response to the L-Glu, L-Lys, L-Phe terpolymer in man. Am J Hum Genet (1985) 0.75
Influence of donor characteristics on responsiveness of mononuclear cells to pokeweed mitogen. Clin Exp Immunol (1989) 0.75
HLA typing as a method of genetic counselling in congenital adrenal hyperplasia. Arch Dis Child (1982) 0.75
Improved kidney graft survival in Eurotransplant by HLA-DR matching and prospectively given blood transfusions. Ulster Med J (1981) 0.75
Genetic and clinical determinants for the T cell mediated immune response against the cornea specific protein BCP 54. Br J Ophthalmol (1994) 0.75
Graves' disease: immunological and immunogenetic indicators of relapse. Br Med J (Clin Res Ed) (1988) 0.75
Idiopathic nephrotic syndrome in Polish children - its variants and associations with HLA. Pediatr Nephrol (2006) 0.75
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Y-antigen killing by T cells of women is restricted by HLA. Nature (1977) 2.73
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
The use of a vertical illuminator with interchangeable dichroic mirrors for fluorescence microscopy with incidental light. Z Wiss Mikrosk (1967) 2.53
HLA-linked genetic control of host response to Mycobacterium leprae. Lancet (1976) 2.45
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science (1988) 2.28
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
HLA-DW3 associated with coeliac disease. Lancet (1976) 1.79
Quantitative immunofluorescence. Standardization and calibration in microfluorometry. Histochemie (1971) 1.69
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60
The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens (1975) 1.54
Possible implications of the effect of blood transfusion on allograft survival. Lancet (1983) 1.46
In vitro immune responsiveness to vaccinea virus and HLA. N Engl J Med (1977) 1.43
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Anti HL-A2 inhibitor in normal human serum. Nature (1970) 1.40
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet (1977) 1.37
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature (1983) 1.34
Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. Ann Rheum Dis (1984) 1.33
Mixed lymphocyte culture and HL-A. Transplant Proc (1972) 1.33
Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation (1984) 1.32
Locomotion and adhesion of neutrophil granulocytes. Effects of albumin, fibrinogen and gamma globulins studied by reflection contrast microscopy. Exp Cell Res (1979) 1.31
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30
Genetic control of survival in epidemics. J Immunogenet (1979) 1.28
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
The HL-A system. I. Genetics and molecular biology. Semin Hematol (1974) 1.26
Typing for MLC (LD). II. The selection of nonstimulator cells by MLC inhibition tests using SD-indentical stimulator cells (MISIS) and fluorescence antibody studies. Transplant Proc (1973) 1.26
Efficacy of HL-A matching in Eurotransplant. Lancet (1972) 1.25
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer (1987) 1.25
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
A study of filters and light sources in immunofluorescence microscopy. Ann N Y Acad Sci (1971) 1.23
Multiple fluorescence in situ hybridization. Cytometry (1990) 1.22
Alloimmunity to human H-Y. Lancet (1976) 1.20
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. N Engl J Med (1982) 1.18
Microfluorometry on antigen-antibody interaction in immunofluorescence using antigens covalently bound to agarose beads. J Immunol Methods (1973) 1.17
The present state of the automated micronucleus test for lymphocytes. Int J Radiat Biol (1990) 1.16
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Platelet and granulocyte specific allo-antigens in chimpanzees. Tissue Antigens (1983) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Letter: HL-A 27 and ankylosing spondylitis. Lancet (1975) 1.13
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A. Transplant Proc (1973) 1.09
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation (1996) 1.07
HL-A identical phenotypes and genotypes in unrelated individuals. Lancet (1970) 1.07
Cadaveric graft survival, clinical course, blood transfusion, HLA (A and B) match, and DR match in adult patients transplanted in one centre. Proc Eur Dial Transplant Assoc (1979) 1.07
[Position of a locus determining mixed lymphocyte reaction distinct from the known HL-A loci]. Eur J Immunol (1972) 1.06
Joint report of 1st International Workshop on Canine Immunogenetics. Tissue Antigens (1973) 1.06
Leukocyte typing and kidney transplantation in unrelated donor-recipient pairs. A study in patients of Drs. S. Peart, J.F.Mowbray, and G.R.J. Alexandre. Transplant Proc (1969) 1.06
Evidence for two series of B-cell antigens in man and their comparison with HLA-D. Scand J Immunol (1977) 1.05
Influence of a single blood transfusion on kidney allograft survival in unrelated rhesus monkeys. Transplantation (1978) 1.04
The quest for a bone marrow donor--optimal or maximal HLA matching? N Engl J Med (1998) 1.04
Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement. Anal Quant Cytol (1984) 1.03
An immunofluorescence reaction for Schistosoma manosoni using the defined antigen substrate spheres (DASS) system. J Immunol Methods (1974) 1.03
The importance of H-Y incompatibility in human organ transplantation. Transplantation (1978) 1.03
Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J Exp Med (1989) 1.02
B-cell antibodies, Ia-like determinants, and their relation to MLC determinants in man. Transplant Rev (1976) 1.02
Mapping SB in relation to HLA and GLO1 using cells from first-cousin marriage offspring. Immunogenetics (1983) 1.01
HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML). Tissue Antigens (1976) 1.01
Interaction of penicillin with HLA-A and -B antigens. Hum Immunol (1982) 1.01
Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3. Clin Exp Immunol (1984) 1.01
Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy (2004) 1.01
HLA antigen distribution and HLA haplotype segregation in Crohn's disease. Tissue Antigens (1980) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
HLA-linked lymphocyte activating determinants. Immunol Rev (1982) 0.99
Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors. J Exp Med (1979) 0.99
Distribution of endothelial-monocyte and HLA antigens on renal vascular endothelium. Transplant Proc (1981) 0.98
Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. Immunol Lett (1981) 0.97
Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency. Clin Immunol Immunopathol (1979) 0.97
Mixed lymphocyte cultures and HL-A. Transplant Proc (1971) 0.96
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med (1986) 0.96
Mixed-lymphocyte-culture and skin-graft data in unrelated HL-A identical individuals. Lancet (1971) 0.96
Clinical experience with bone marrow transplantation: failure and success. Transplant Proc (1971) 0.96
HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J Infect Dis (1980) 0.96
HLA-linked control of the course of M. leprae infections. Lepr Rev (1981) 0.96
Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts. Transplantation (1979) 0.95
Matching for HLA antigens of A, B, and DR loci in renal transplantation by Eurotransplant. Lancet (1978) 0.94